Rare diseases
Investigational molecules
Locations
Back to Czechia1 231 clinical trials in Prague, Czechia across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
CzechiaStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
CzechiaStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
CzechiaStudy of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks
CzechiaStudy of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration
CzechiaStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
CzechiaEvaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression
CzechiaLong-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder
CzechiaStudy of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
CzechiaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
CzechiaClinical Trial for Patients with Chronic Hepatitis D: Comparing Brelovitug and Bulevirtide Treatments
CzechiaStudy on the Safety and Effectiveness of Telisotuzumab Adizutecan and Drug Combination for Patients with Metastatic Colorectal Cancer
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in Praha includes research in advanced melanoma and diffuse large B-cell lymphoma, with a strong focus on improving cancer control and extending survival.
These studies are designed to refine how immunotherapy and other cancer treatments perform in everyday clinical care.
Research in cardiovascular diseases is centered on reducing major heart and vascular events, with trials looking at hypertension, atherosclerotic cardiovascular disease, and heart failure prevention.
Several studies aim to improve treatment effectiveness for patients at elevated cardiovascular risk.
Trials in the respiratory field focus on better symptom control and fewer flare-ups in chronic obstructive pulmonary disease, alongside ongoing work in infection-related lung illness.
These studies support more effective care for both chronic and acute respiratory conditions.
Dermatology research in Czechia includes several inflammatory skin disorders, with studies targeting itch, lesion control, and long-term disease management.
The goal is to evaluate new therapies that may ease symptoms and improve quality of life.
Studies in immune-mediated disease are exploring treatments that can calm abnormal inflammation while maintaining safety and tolerability.
These trials aim to improve control of chronic immune-driven disease burden.
Neurology-related research focuses on agitation in Alzheimer's disease dementia, with efforts to better manage behavioral symptoms that affect patients and caregivers.
These studies may help support more practical care for people living with dementia.
Metabolic research in Praha includes trials for overweight, obesity, and related conditions, often linked with cardiovascular risk.
These studies are testing approaches that may help reduce long-term health risks tied to excess weight.
In the area of virus diseases, research is centered on improving treatment options for people with COVID-19 who are at higher risk of becoming seriously ill.
The main aim is to help prevent worsening disease and support faster recovery.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
